Gene-editing tool approved for 1st human trials
A US panel has approved the first ever human trials of the CRISPR-Cas9 gene-editing technique, proposed by University of Pennsylvania researchers. The team aims to modify the immune system "T cells" in patients, helping them better fight off several cancer types. CRISPR-Cas9 is currently one of the fastest, simplest and cheapest tools that help geneticists edit parts of a genome.